These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 28137301

  • 1. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS, Shih SC, Wang HY, Lin CC, Chang CW, Chen MJ.
    BMC Gastroenterol; 2017 Jan 31; 17(1):22. PubMed ID: 28137301
    [Abstract] [Full Text] [Related]

  • 2. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
    Law ST, Lee MK, Lee AS, Tung Y, Li KK.
    J Dig Dis; 2016 May 31; 17(5):325-33. PubMed ID: 27085094
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S, Park JY, Song K, Kim DY, Kim BK, Kim SU, Ku HJ, Han KH, Ahn SH.
    Gut Liver; 2015 Nov 23; 9(6):776-83. PubMed ID: 25963085
    [Abstract] [Full Text] [Related]

  • 4. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST, Lee MK, Li KK, Mok CK.
    Eur J Gastroenterol Hepatol; 2016 Feb 23; 28(2):193-8. PubMed ID: 26587867
    [Abstract] [Full Text] [Related]

  • 5. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M, Oh S, Lee HJ, Yeum TS, Lee JH, Yu SJ, Kim HY, Yoon JH, Lee HS, Kim YJ.
    J Viral Hepat; 2014 Dec 23; 21(12):873-81. PubMed ID: 24351112
    [Abstract] [Full Text] [Related]

  • 6. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
    Wu X, Cai S, Li Z, Zheng C, Xue X, Zeng J, Peng J.
    Virol J; 2016 Apr 09; 13():64. PubMed ID: 27062520
    [Abstract] [Full Text] [Related]

  • 7. Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification.
    Choi JW, Kim SH, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Lee YK, Lee CK.
    Yonsei Med J; 2018 May 09; 59(3):383-388. PubMed ID: 29611400
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
    Cai S, Cao J, Yu T, Xia M, Peng J.
    Medicine (Baltimore); 2017 Jun 09; 96(22):e7021. PubMed ID: 28562554
    [Abstract] [Full Text] [Related]

  • 9. Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy.
    Liu B, Shen B, Mei M, Li L, Wang X, Zhao H.
    Ther Apher Dial; 2020 Feb 09; 24(1):56-63. PubMed ID: 31090170
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis.
    Shen H, Ding F, Wang Z, Sun F, Yu Y, Zhou J, Xu W, Ni J, Wang J, Yang Y.
    Cell Physiol Biochem; 2016 Feb 09; 40(1-2):370-378. PubMed ID: 27866195
    [Abstract] [Full Text] [Related]

  • 11. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC, Chen CH, Tseng PL, Hung CH, Chiu KW, Wang JH, Lu SN, Lee CM, Chang KC, Yen YH, Lin MT, Chou YP, Hu TH.
    Clin Microbiol Infect; 2016 Jan 09; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [Abstract] [Full Text] [Related]

  • 12. Impact of nucleos(t)ide analogue combination therapy on the estimated glomerular filtration rate in patients with chronic hepatitis B.
    Qi X, Wang J, Chen L, Huang Y, Qin Y, Mao R, Zhang J.
    Medicine (Baltimore); 2015 Apr 09; 94(15):e646. PubMed ID: 25881837
    [Abstract] [Full Text] [Related]

  • 13. Telbivudine and adefovir dipivoxil combination therapy improves renal function in patients with chronic hepatitis B: A STROBE-compliant article.
    Xu Y, Nie ZW.
    Medicine (Baltimore); 2018 Nov 09; 97(48):e13430. PubMed ID: 30508954
    [Abstract] [Full Text] [Related]

  • 14. Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China.
    Qi X, Wang JY, Mao RC, Zhang JM.
    J Viral Hepat; 2015 Jan 09; 22(1):46-54. PubMed ID: 25402626
    [Abstract] [Full Text] [Related]

  • 15. Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    Tsai MC, Chen CH, Tseng PL, Hung CH, Chiu KW, Chang KC, Yen YH, Lin MT, Hu TH.
    PLoS One; 2016 Jan 09; 11(3):e0149761. PubMed ID: 26964034
    [Abstract] [Full Text] [Related]

  • 16. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
    Li W, Zhang D.
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun 09; 23(6):407-11. PubMed ID: 26236924
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H.
    J Viral Hepat; 2013 Apr 09; 20 Suppl 1():40-5. PubMed ID: 23458523
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patients.
    Wu Y, Jie Y, Li X, Huang M, Li X, Shi H, Chen S, Zhang M, Ao Y, Yang F, Gao Z, Lin G, Chong Y.
    Clin Res Hepatol Gastroenterol; 2016 Apr 09; 40(2):213-20. PubMed ID: 26598028
    [Abstract] [Full Text] [Related]

  • 19. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC, Chen CH, Hung CH, Lee CM, Chiu KW, Wang JH, Lu SN, Tseng PL, Chang KC, Yen YH, Hu TH.
    Clin Microbiol Infect; 2014 Feb 09; 20(2):O90-O100. PubMed ID: 23659493
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR, Yim HJ, Kang S, Suh SJ, Kim SY, Hyun JJ, Koo JS, Kim JH, Seo YS, Yeon JE, Lee SW, Byun KS, Um SH.
    Liver Int; 2015 Mar 09; 35(3):860-9. PubMed ID: 24905912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.